X
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Online Resource
    Online Resource
    Probiotic bacteria and their effect on human health and well-being / (2013)
    Basel :Karger,
    Details
    UID:
    almahu_BV041395707
    Format: 1 Online-Ressource (XII, 202 Seiten) : , Illustrationen, Diagramme.
    ISBN: 978-3-318-02325-1
    Series Statement: World review of nutrition and dietetics Vol. 107
    Content: Our microflora is an individual personal feature, providing a distinct tag to individuals. However, our intestinal microbiome is strongly affected by genetic, nutritional, and other external factors, and evolves with age. An effect of different microbial patterns on health appears very likely as there seem to be specific changes of intestinal microflora associated with various diseases. Specific microbial tags may thus be used as biomarkers of disease: to diagnose it, to monitor its evolution, and eventually to predict its response to treatment. This scenario opens the opportunity for targeting intestinal microflora using probiotics, both for prevention and treatment of an increasing number of conditions. Probiotic therapy is applied either as an adjunct to other treatments or as primary therapy, and evidence of efficacy is accumulating in several conditions, affecting either the intestine or nonintestinal organs. This publication provides an update on probiotics directed at physicians, biologists, biotechnologists, and researchers working in the food industry and agriculture, as well as in the environmental and basic sciences
    Note: An update on intestinal microbiota and probiotics
    Additional Edition: Erscheint auch als Druck-Ausgabe ISBN 978-3-318-02324-4
    Language: English
    Subjects: Medicine
    RVK:
    XI 4900
    Keywords: Probiotikum ; Aufsatzsammlung ; Electronic books ; Aufsatzsammlung
    DOI: 10.1159/isbn.978-3-318-02325-1
    URL: Volltext
    URL: Volltext  (Deutschlandweit zugänglich)
    URL: lizenzpflichtig
    Author information: Quigley, Eamonn M.
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Online Access
    Open Access Request
    Stabi Berlin
    HU Berlin
    UB Potsdam
    MPI Bildungsforschung
  • 2
    Online Resource
    Online Resource
    Irritable bowel syndrome : diagnosis and clinical management (2013)
    Chichester, West Sussex :Wiley-Blackwell,
    Details
    UID:
    almafu_9959328660802883
    Format: 1 online resource (336 pages) : , illustrations
    Edition: First edition.
    ISBN: 9781118444689 , 111844468X , 9781118444757 , 1118444752 , 9781118444740 , 1118444744
    Content: This comprehensive yet concise guide to the diagnosis and management of IBS is divided into four main parts: Overview, Diagnosis, Symptom-specific Treatment, and What's Next in IBS. Each chapter includes a summary of key points, and most chapters include cases and multiple choice questions for rapid review. Clinicians who manage patients with IBS will want to keep this dependable reference close at hand.
    Note: Edition statement from running title area. , Overview of irritable bowel syndrome -- Definitions and classifications of irritable bowel syndrome -- Epidemiology of irritable bowel syndrome -- Global impact of irritable bowel syndrome -- Diagnosis of irritable bowel syndrome -- What is the best way to identify and quantify irritable bowel syndrome? -- Practical approach to clinical assessment of irritable bowel syndrome -- Interface between primary care and secondary care -- Symptom-specific treatment of irritable bowel syndrome -- Self-management strategies for irritable bowel syndrome -- Food-related symptoms of irritable bowel syndrome -- Gut inflammation in irritable bowel syndrome -- Psychological factors and treatments in irritable bowel syndrome -- Gut motility related symptoms -- Gut hypersensitivity related symptoms -- Abdominal bloating -- Sequencing the treatments: the book in one chapter! -- What's next in irritable bowel syndrome -- Diagnostic and therapeutic horizons for irritable bowel syndrome.
    Additional Edition: Print version: Irritable bowel syndrome. Chichester, West Sussex : John Wiley & Sons, 2013 ISBN 9781118538623
    Language: English
    Keywords: Handbook. ; Electronic books. ; Handbook. ; Electronic books. ; Handbook. ; Electronic books.
    URL: https://onlinelibrary.wiley.com/doi/book/10.1002/9781118444689
    URL: https://onlinelibrary.wiley.com/doi/book/10.1002/9781118444689
    URL: https://onlinelibrary.wiley.com/doi/book/10.1002/9781118444689
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    HU Berlin
    FU Berlin
  • 3
    Online Resource
    Online Resource
    Irritable Bowel Syndrome : diagnosis and clinical management (2013)
    New York :Wiley,
    Details
    UID:
    almahu_9948317023002882
    Format: 336 p.
    Edition: Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
    Language: English
    Keywords: Electronic books.
    URL: Click to View
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    HU Berlin
  • 4
    Online Resource
    Online Resource
    Probiotic bacteria and their effect on human health and well-being / (2013)
    Basel ; : Karger,
    Details
    UID:
    almafu_9959076721102883
    Format: 1 online resource (216 p.)
    ISBN: 3-318-02325-6
    Series Statement: World review of nutrition and dietetics, volume 107
    Content: Our microflora is an individual personal feature, providing a distinct tag to individuals. However, our intestinal microbiome is strongly affected by genetic, nutritional, and other external factors, and evolves with age. An effect of different microbial patterns on health appears very likely as there seem to be specific changes of intestinal microflora associated with various diseases. Specific microbial tags may thus be used as biomarkers of disease: to diagnose it, to monitor its evolution, and eventually to predict its response to treatment. This scenario opens the opportunity for targeting intestinal microflora using probiotics, both for prevention and treatment of an increasing number of conditions. Probiotic therapy is applied either as an adjunct to other treatments or as primary therapy, and evidence of efficacy is accumulating in several conditions, affecting either the intestine or nonintestinal organs. This publication provides an update on probiotics directed at physicians, biologists, biotechnologists, and researchers working in the food industry and agriculture, as well as in the environmental and basic sciences.
    Note: Description based upon print version of record. , Probiotics : definition and taxonomy 10 years after the FAO/WHO guidelines / L. Morelli -- Intestinal microbiota composition in children / volume Buccigrossi -- Intestinal microbiota composition in adults / volume Robles-Alonso, F. Guarner -- The intestinal microbiota and aging / P.W. O'Toole, P. Brigidi -- Shaping intestinal bacterial community by TLR and NLR signaling / K.S. Kobayashi -- Importance of early microbial colonization for intestinal immune development / P. Brandtzaeg -- Effects of the intestinal microbiota on behavior and brain biochemistry / E. Barrett ... [et al.] -- Relationship between bacterial colonization of human digestive and respiratory tract / S.volume Lynch -- Probiotics in the prevention and treatment of inflammatory bowel diseases in children / B. Pigneur, F.M. Ruemmele -- Functional gastrointestinal disorders in children / F. Indrio, G. Fiezzo -- Functional gastrointestinal disorders in adults / E.M.M. Quigley -- Metabolic syndrome and obesity in children / R. Luoto ... [et al.] -- Metabolic syndrome and obesity : adults / S.E. Power ... [et al.] -- Neonatal necrotizing enterocolitis / J. Neu -- Role of probiotics in allergies / R.B. Canani ... [et al.] -- Probiotics in respiratory infections / E. Bruzzese, A. Lo Vecchio, E. Ruberto -- Are probiotic effects dose-related? / T.J. Patton, S. Guandalini -- Safety of probiotics / I. Hojsak, R. Shamir -- Age-related functional feeding : a novel tool to improve the quality of life / S. Forssten ... [et al.] -- Use of microbes to fight microbes / C. Hill -- What is the future for therapies derived from the microbiome (pharmabiotics)? / G.T. Rijkers ... [et al.]. , English
    Additional Edition: ISBN 3-318-02324-8
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Charité
  • 5
    Online Resource
    Online Resource
    Spectrum of GERD implications for assessment and management / (2011)
    London, England :Henry Stewart Talks Ltd,
    Details
    UID:
    almafu_9961427323802883
    Format: 1 streaming video file (40 min.) : , sound, color , 003936
    Note: Retrieved April 13, 2024, from https://hstalks.com/bs/1945/. , Introduction -- Issues in GERD -- Definition of GERD -- Los Angeles classification -- Get your definitions right -- NERD is important -- Prevalence of GERD (1) -- Prevalence of GERD (2) -- Symptom relief after 4 weeks in NERD patients -- Predictors of NERD vs. ERD -- NERD is not homogenous -- 24-hr pH study -- Is most NERD MERD? -- Mechanisms of symptom production in NERD -- Sub classification of NERD -- Functional heartburn (1) -- Predictors of functional heartburn vs. pH + NERD -- Development of symptoms in GERD patients -- Laparoscopic fundoplication -- Functional heartburn (2) -- Role of DGER in "resistant" GERD -- NERD: management issues -- What are the limits of GERD? -- Heartburn and quality of life (1) -- Heartburn and quality of life (2) -- GERD in China (1) -- GERD in China (2) -- Symptom severity and quality of life -- Natural history -- Progression in ProGERD (1) -- Progression in ProGERD (2) -- Determination of GERD -- Extra-esophageal, supra-esophageal GERD -- Laryngitis -- Non-acid reflux -- Cough and GERD -- Meta-analysis of primary outcome -- Meta-analysis of cough scores -- Cochrane -- Non-traditional reflux and cough -- Asthma -- PPI and asthma (1) -- PPI and asthma (2) -- Scleroderma and GERD -- The Barrett's dilemma -- How do we proceed? -- Risk factors for Barrett's and adenocarcinoma -- Can we predict progression? -- Genetics -- Screen followed by surveillance? -- Prague criteria -- Barrett's management issues -- GERD management issues -- Summary - approaches to the patients with GERD -- Issues in choosing a PPI -- Key points.
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Charité
  • 6
    Online Resource
    Online Resource
    Irritable bowel syndrome (IBS) / (2011)
    London :Henry Stewart Talks Ltd,
    Details
    UID:
    almafu_9961427325402883
    Format: 1 videorecording (1 hr., 12 min., 49 sec.) : , sound, color. , 011249
    Series Statement: Henry Stewart talks
    Note: Retrieved April 15, 2024, from https://hstalks.com/bs/1913/. , Introduction -- Irritable Bowel Syndrome (IBS) -- What is IBS? -- "Classical" IBS is a coherent entity -- IBS in the "real" world! -- IBS features -- IBS: Rome III definition (1) -- IBS: Rome III definition (2) -- A more clinician-friendly definition? -- Criteria-based definition of IBS -- The irritable colon syndrome study (1) -- The irritable colon syndrome study (2) -- We have ignored the rest of the world! -- Global prevalence of IBS 2005 -- Regional variations -- IBS pathophysiology -- The gut brain axis in IBS (1) -- The gut brain axis in IBS (2) -- A new paradigm -- Evidence for a role for the gut flora in IBS -- Post infectious IBS -- Walkerton, Ontario -- Long term outcome, does PI- IBS go away? -- CSGNA outbreak - Norovirus -- Lessons from PI- IBS -- Direct evidence of an altered gut flora, SIBO -- Another explanation for antibiotic effect in IBS? -- Altered colonic flora -- GI microbiota in IBS -- The fecal flora in IBS -- Colonic biofilm -- Physiological effects of an altered flora -- Altered flora causing alterations in gas volume -- Mediator of pro-inflammatory state -- Pro-inflammatory state -- Systemic and mucosal immune system -- Systemic compartment (1) -- Systemic immune compartment in IBS -- Alternative approach to IBS pathophysiology (1) -- IBS and somatic co-morbidity -- Alternative approach to IBS pathophysiology (2) -- Significance of changes in inflammatory markers -- ACTH response to CRH -- The mucosal immune system -- Mucosal compartment (1) -- Beta-defensin 2 in IBS -- Mucosal compartment (2) -- Can we link bacteria, inflammation and IBS? -- Is this a form of IBD? -- Calprotectin in IBS -- IBS symptoms in IBD? -- Crohn's Disease -- Ulcerative Colitis -- Therapeutic impact of altering flora -- Antibiotics -- Rifaximin -- Probiotics -- Anti-inflammatories -- Mesalazine in IBS -- Food, diet and IBS: role in pathophysiology -- Food intake and GI symptoms -- Food scores in IBS -- Why does food provoke symptoms in IBS? -- Physiological effects of food -- Diet and IBS -- Food allergy in IBS -- IgG responses in IBS (1) -- IgG responses in IBS (2) -- Gluten-reactive IBS (1) -- Gluten-reactive IBS (2) -- Food intolerance in IBS -- Diagnosis -- Yield of tests in IBS -- Prevalence of organic disease in IBS -- Management -- Food, diet and IBS: role in management -- Fiber/bulking agents for IBS -- Probiotics -- Prebiotics (1) -- Probiotics in IBS, pre 2000 -- Probiotics in IBS, from 2000 -- Study design -- Pain, VAS scale -- Composite score -- Systemic compartment (2) -- Bifidobacterium in IBS -- Abdominal pain or discomfort -- Bloating -- Global assessment of symptom relief -- Bif. animalis in C-IBS -- Bifidobacterium lactis DN 173 010 (1) -- Bifidobacterium lactis DN 173 010 (2) -- What about the long-term? -- Prebiotics (2) -- Prebiotics and synbiotics in IBS -- IBS: pharmacological and other approaches -- Antispasmodics -- Cochrane study -- Anti-depressants for IBS -- Anti-depressants in IBS -- New approaches -- Targets -- Challenges in drug development -- Significance -- New targets (1) -- Serotonin -- Tegaserod -- Alosetron -- New targets (2) -- Lubiprostone in C-IBS -- Psychotherapy and hypnotherapy -- What do we need to know? -- Conclusions.
    Language: English
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
    Online Resource
    Charité
Nothing or not found what you are looking for? Please check your search query or use the Interlibrary Loan Search.
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages